#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic lymphocytic leukaemia refractory Antisynthetase syndrome Astrocytoma High-grade B-cell lymphoma Brain injury Haemophilia B without inhibitors Hypophosphatasia Behcet's syndrome Autoimmune hepatitis HER2 gene amplification Factor IX deficiency Vascular calcification Amyotrophic lateral sclerosis gene carrier Adrenocortical carcinoma ABO haemolytic disease of newborn More trials…

    Learn about Rare Diseases

    KBG syndrome – Trials in Disease Wiskott-Aldrich syndrome – Trials in Disease Ewing’s sarcoma – Life with Disease Gaucher’s disease type I Paroxysmal nocturnal haemoglobinuria – Basic Information Prader-Willi syndrome Activated PI3 kinase delta syndrome – Diagnostics Haemophilia B without inhibitors – Diagnostics Hereditary angioedema – Trials in Disease Glomerulonephritis membranous – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Msv-Allo Rocuronium Bromide Cladribine F770/05 Ixazomib Citrate Bepirovirsen Metoprolol Succinate Rmc-035 BENZYLPENICILLIN POTASSIUM RIMIDUCID Vidofludimus Calcium Dexketoprofen Trometamol ORG-129 Wt1 Mrna Dc COLESEVELAM HYDROCHLORIDE Mirodenafil Dihydrochloride Trimethoprim NERANDOMILAST Oteracil Rintatolimod More therapies…

    Learn about Your Condition

    Hereditary angioedema Peritoneal neoplasm Malignant melanoma Conjunctivitis allergic Neurogenic bladder Endometrial cancer stage I Embolic stroke Persistent depressive disorder Arrhythmia supraventricular Muscle hypertrophy Liposarcoma metastatic Pituitary tumour benign Metastases to peritoneum Bladder cancer stage III Otitis media More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study of Sigvotatug Vedotin and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with High PD-L1 Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Pembrolizumab
    • SIGVOTATUG VEDOTIN
    Austria Belgium Bulgaria Czechia Denmark France +9

  • Study on the Safety and Effectiveness of Bexicaserin for Seizures in Children and Adults with Developmental and Epileptic Encephalopathy

    Recruiting

    3 1
    Investigated Diseases:
    • Epileptic encephalopathy
    Belgium France Germany Italy Latvia The Netherlands +2

  • Study Comparing BGB-16673 to Drug Combinations for Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Treated with BTK and BCL2 Inhibitors

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • B-cell small lymphocytic lymphoma
    • Chronic lymphocytic leukaemia
    Investigated Drugs:
    • BGB-16673
    • Idelalisib
    • Bendamustine Hydrochloride
    Czechia Germany Italy The Netherlands Poland

  • Study on the Safety and Effectiveness of Sovateltide for Patients with Acute Ischemic Stroke

    Recruiting

    3 1
    Investigated Diseases:
    • Cerebrovascular accident
    Investigated Drugs:
    • SOVATELTIDE
    Germany Spain

  • Study of Acalabrutinib with R-CHOP for Patients with Untreated Mantle Cell Lymphoma in Spain

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Acalabrutinib
    Spain

  • Study of Ifinatamab Deruxtecan and Chemotherapy for Patients with Advanced or Metastatic Esophageal Squamous Cell Carcinoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ifinatamab Deruxtecan
    • Docetaxel
    • Irinotecan Hydrochloride
    Belgium Denmark France Germany Italy The Netherlands +5
Previous Page
1 … 181 182 183 184 185 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!